EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aβ25-35-induced autophagy and apoptosis are prevented by the CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR signaling hub

Yingshi Ji, Jinghong Ren, Yuan Qian, Jiaxin Li, Huanyu Liu, Yuan Yao, Jianfeng Sun, Rajesh Khanna, Li Sun iD

PLOS ONE · 26.09.2024 · 19 (9) · e0309794

DOI: 10.1371/journal.pone.0309794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 26.09.2024. Verfasst von Yingshi Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, PR China. Hauptthemen laut MEDLINE: Apoptosis, Amyloid beta-Peptides, Autophagy, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Chronic Disease Program of the Ministry of Science and Technology of China, General Program of the National Natural Science Foundation of China, Jilin Provincial Department of Finance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously reported that the peptide ST2-104 (CBD3, for Ca 2+ channel-binding domain 3), derived from the collapsin response mediator protein 2 (CRMP2)–a cytosolic phosphoprotein, protects neuroblastoma cells against β-amyloid (Aβ) peptide-mediated toxicity through engagement of a phosphorylated CRMP2/NMDAR pathway. Abnormal aggregation of Aβ peptides (e.g., Aβ 25–35 ) leads to programmed cell death (apoptosis) as well autophagy–both of which contribute to Alzheimer’s disease (AD) progression. Here, we asked if ST2-104 affects apoptosis and autophagy in SH-SY5Y neuroblastoma challenged with the toxic Aβ 25–35 peptide and subsequently mapped the downstream signaling pathways involved. ST2-104 protected SH-SY5Y cells from death following Aβ 25–35 peptide challenge by reducing apoptosis and autophagy as well as limiting excessive calcium entry. Cytotoxicity of SHY-SY5Y cells challenged with Aβ 25–35 peptide was blunted by ST2-104. The autophagy activator Rapamycin blunted the anti-apoptotic activity of ST2-104. ST2-104 reversed Aβ 25-35 -induced apoptosis via inhibiting Ca 2+ /CaM-dependent protein kinase kinase β (CaMKKβ)-mediated autophagy, which was partly enhanced by STO-609 (an inhibitor of CaMKKβ). ST2-104 attenuated neuronal apoptosis by inhibiting autophagy through a CaMKKβ/AMPK/mTOR signaling hub. These findings identify a mechanism whereby, in the face of Aβ 25–35 , the concerted actions of ST2-104 leads to a reduction in intracellular calcium overload and inhibition of the CaMKKβ/AMPK/mTOR pathway resulting in attenuation of autophagy and cellular apoptosis. These findings define a mechanistic framework for how ST2-104 transduces “outside” (calcium channels) to “inside” signaling (CaMKKβ/AMPK/mTOR) to confer neuroprotection in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisAmyloid beta-PeptidesAutophagyTOR Serine-Threonine KinasesCalcium-Calmodulin-Dependent Protein Kinase KinasePeptide FragmentsSignal TransductionAMP-Activated Protein KinasesIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsHumansCell Line, TumorCalcium

Substanzen

Amyloid beta-Peptidesamyloid beta-protein (25-35)TOR Serine-Threonine KinasesCalcium-Calmodulin-Dependent Protein Kinase KinasePeptide FragmentsAMP-Activated Protein KinasesIntercellular Signaling Peptides and Proteinscollapsin response mediator protein-2Nerve Tissue ProteinsMTOR protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, PR China.
  • Beijing Jishuitan Hospital, Peking University Fourth School of Clinical Medicine, Beijing, PR China.
  • Department of Physiology, Jilin University, Changchun, Jilin, PR China.
  • Department of Pharmacology & Therapeutics, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Pain and Addiction Therapeutics (PATH) Collaboratory, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • Department of Neurology and Neuroscience Center, The First Hospital, Jilin University, Changchun, Jilin, PR China.

ORCID-Profile: Li Sun

Förderung

  • Major Chronic Disease Program of the Ministry of Science and Technology of China
  • General Program of the National Natural Science Foundation of China
  • Jilin Provincial Department of Finance
  • the Jilin Science and Technology Department

Zitieren

APA

Ji, Y., Ren, J., Qian, Y., Li, J., Liu, H., Yao, Y., Sun, J., Khanna, R., & Sun, L. (2024). Aβ25-35-induced autophagy and apoptosis are prevented by the CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR signaling hub. PLOS ONE, 19(9), e0309794. https://doi.org/10.1371/journal.pone.0309794

Vancouver

Ji Y, Ren J, Qian Y, Li J, Liu H, Yao Y, et al. Aβ25-35-induced autophagy and apoptosis are prevented by the CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR signaling hub. PLOS ONE. 2024;19(9):e0309794. doi:10.1371/journal.pone.0309794

BibTeX
@article{Ji2024,
  author = {Ji, Yingshi and Ren, Jinghong and Qian, Yuan and Li, Jiaxin and Liu, Huanyu and Yao, Yuan and Sun, Jianfeng and Khanna, Rajesh and Sun, Li},
  title = {Aβ25-35-induced autophagy and apoptosis are prevented by the CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR signaling hub},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0309794},
  doi = {10.1371/journal.pone.0309794}
}
Kostenlos starten →